Jean-François Pariseau is a Partner in the Healthcare Fund of BDC Capital. He joined BDC Capital in 2001 and has over 20 years of investment and entrepreneurial experience in the healthcare sector.
Prior to joining BDC, Jean-François was an investment manager with CDP Capital Technology Ventures, a $2 billion global fund investing in healthcare, information technology and advanced technologies, where he was responsible for healthcare investments in Canada and the US.
He has invested and managed more than $200 million in biopharmaceutical and medical device companies in North America. His experience includes transactions in private and in public companies, IPOs, M&A and fund investments. Prior to this, he was Chief Executive Officer of a consulting company specializing in regulatory affairs, and was Vice President, Research & Development for a pharmaceutical-product distribution company, both of which he founded.
Jean-François currently sits on the Board of Directors of AngioChem, Clementia Pharmaceutical, Profound Medical (TSXV: PRN) and Imagia Cybernetics.